Murdoch Childrens Research Institute donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country
Facebook page MurdochChildrensResearchInstitute
Websitehttps://www.mcri.edu.au/
Twitter usernameMCRI_for_kids
Wikipedia pagehttps://en.wikipedia.org/wiki/Murdoch_Childrens_Research_Institute
Instagram usernamemurdoch_childrens

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 23 1,248,889 1,635,236 112,973 265,696 349,992 506,656 599,983 1,248,889 1,477,882 1,799,668 2,999,775 4,771,414 4,992,818
Global health 23 1,248,889 1,635,236 112,973 265,696 349,992 506,656 599,983 1,248,889 1,477,882 1,799,668 2,999,775 4,771,414 4,992,818

Donation amounts by donor and year for donee Murdoch Childrens Research Institute

Donor Total 2017 2016 2015 2014 2013 2012 2011 2009
Bill and Melinda Gates Foundation (filter this donee) 37,610,417.00 3,623,428.00 5,368,934.00 5,387,102.00 12,977,601.00 6,072,998.00 1,432,366.00 1,499,099.00 1,248,889.00
Total 37,610,417.00 3,623,428.00 5,368,934.00 5,387,102.00 12,977,601.00 6,072,998.00 1,432,366.00 1,499,099.00 1,248,889.00

Full list of donations in reverse chronological order (23 donations)

DonorAmount (current USD)Amount rank (out of 23)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation278,947.0042017-11-15Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to generate robust data as part of the single-dose HPV evidence generation process; Aid type: Project-type interventions. Affected countries: Fiji.
Bill and Melinda Gates Foundation599,983.00102017-11-03Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide support for a project manager to provide targeted clinical and regulatory support to BioFarma’s RV3 rotavirus vaccine development program; Aid type: Project-type interventions. Affected countries: Indonesia.
Bill and Melinda Gates Foundation112,973.0012017-11-03Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to generate robust data as part of the single-dose HPV evidence generation process.; Aid type: Project-type interventions. Affected countries: Mongolia.
Bill and Melinda Gates Foundation496,438.0062017-11-03Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to evaluate nasopharyngeal carriage in children with pneumonia 4 years post introduction of pneumococcal conjugate vaccine vaccination to determine herd impact on unimmunized; Aid type: Project-type interventions. Affected countries: Lao people's democratic republic (the).
Bill and Melinda Gates Foundation1,324,476.00132017-08-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide evidence to help understand why vaccine recipients in some instances do not respond to an oral rotavirus vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation253,700.0022017-07-22Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- To support the 11th International Symposium on Pneumococci and Pneumococcal Diseases, the international pneumococcal experts meeting held Melbourne, Australia in 2018.; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation556,911.0082017-04-04Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to fund a substudy of a pneumococcal conjugate vaccine (PCV) impact, to evaluate the impact of PCV-13 introduction on the incidence of respiratory syncytial virus and/or influenza related severe pneumonia among children under age 5; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,799,668.00172016-10-12Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a low cost rotavirus vaccine that could be used in a developing world setting to prevent vaccine preventable deaths in infants and children; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,999,775.00192016-10-05Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to produce immunological and microbiological evidence of the effectiveness of alternate dosing schedules of pneumococcal conjugate vaccines using fewer doses; Aid type: Project-type interventions. Affected countries: Viet nam.
Bill and Melinda Gates Foundation569,491.0092016-08-10Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to overcome the many challenges of getting oxygen to seriously ill children with severe pneumonia in remote rural hospitals and health centers; Aid type: Project-type interventions. Affected countries: Nigeria|Papua new guinea.
Bill and Melinda Gates Foundation265,696.0032015-07-01Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to examine a new mechanism that may influence rotavirus vaccine take, and improve our understanding of immunological correlates of protection; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,771,414.00212015-02-23Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to overcome the many challenges of getting oxygen to seriously ill children with severe pneumonia in remote rural hospitals and health centers; Aid type: Project-type interventions. Affected countries: Nigeria|Papua new guinea.
Bill and Melinda Gates Foundation349,992.0052015-02-13Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to contribute to the understanding of whether the frequency and intensity of social contact affects pneumococcal carriage rates and density, and if so, whether pneumococcal conjugate vaccination is able to overcome the effects of social contact on the car; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,994,783.00182014-10-24Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to demonstrate how nasopharyngeal (NP) carriage surveillance in hospitalized children with respiratory illness or pneumonia can be used to estimate the pneumococcal conjugate vaccine coverage required to show evidence of herd immunity; Aid type: Project-type interventions. Affected countries: Australia|Lao people's democratic republic (the)|Mongolia|Papua new guinea.
Bill and Melinda Gates Foundation4,990,000.00222014-10-02Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a low cost rotavirus vaccine that could be used in a developing world setting to prevent vaccine preventable deaths in infants and children; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,992,818.00232014-09-24Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to produce immunological and microbiological evidence of the effectiveness of alternate dosing schedules of pneumococcal conjugate vaccines using fewer doses; Aid type: Project-type interventions. Affected countries: Viet nam.
Bill and Melinda Gates Foundation3,096,211.00202013-11-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to monitor pneumococcal carriage and vaccine impact. Monitoring pneumococcal carriage and vaccine impact. Investment start date: 11/14/2013 to end date: 12/31/2016. Grantee name: Murdoch Childrens Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,498,905.00152013-08-27Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop an effective, low cost, oral, human neonatal rotavirus vaccine aimed at prevention of rotavirus gastroenteritis from birth, for infants and children worldwide; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,477,882.00142013-06-25Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop an effective, low cost, oral, human neonatal rotavirus vaccine aimed at prevention of rotavirus gastroenteritis from birth, for infants and children worldwide; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation506,656.0072012-10-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide a pathway to select methods to detect carriage of multiple serotype of Streptococcus pneumoniae that can be used in resource-poor countries to facilitate monitoring of the impact of introducing pneumococcal vaccination; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation925,710.00112012-07-20Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop an effective, low cost, oral, human neonatal rotavirus vaccine aimed at prevention of rotavirus gastroenteritis from birth, for infants and children worldwide; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,499,099.00162011-08-26Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide a pathway to select methods to detect carriage of multiple serotype of Streptococcus pneumoniae that can be used in resource-poor countries to facilitate monitoring of the impact of introducing pneumococcal vaccination; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,248,889.00122009-09-22Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide a pathway to select methods to detect carriage of multiple serotype of Streptococcus pneumoniae that can be used in resource-poor countries to facilitate monitoring of the impact of introducing pneumococcal vaccination; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.